Feinstein Institutes awarded $2.9 million NIH funding for polygenic embryo selection studies
Feinstein Institutes awarded $2.9 million NIH funding for polygenic embryo selection studies Genetic testing and selection of embryos generated from in vitro fertilization (IVF) have given rise to the controversial “designer baby” debate. Recently, the use of a new technology called polygenic embryo selection (PES) has developed to identify the risk for complex diseases of adulthood. To further study the accuracy – and the ethics – of PES, researchers at The Feinstein Institutes for Medical Research have been awarded a $2.9 million grant from the National Institutes of Health's (NIH) ...